# Vertex Announces $10 Billion Takeover Bid for Crinetics Pharmaceuticals

> ma · REPORTED · 2026-07-07

Vertex Pharmaceuticals announced a $10 billion takeover bid for Crinetics Pharmaceuticals, targeting its rare disease drug Palsonify, as part of a broad pharma M&A wave that saw Novartis, Vertex, and Ipsen extend dealmaking into the second half of 2026 with up to $12.6 billion in new deals.

About Vertex Pharmaceuticals: Vertex Pharmaceuticals is a global biotechnology company focused on developing medicines for serious diseases including cystic fibrosis, sickle cell disease, and rare conditions.

- Company: Vertex Pharmaceuticals
- Sector: biotech
- Primary source: https://endpoints.news/novartis-vertex-and-ipsen-extend-pharma-ma-spree-from-2026s-first-half/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.